1 / 6

Sofosbuvir + Ribavirin i n HCV GT 4 Egyptian Ancestry Trial

Phase 2. Treatment Naïve and Treatment Experienced. Sofosbuvir + Ribavirin i n HCV GT 4 Egyptian Ancestry Trial. Ruane P, et al. 49 th EASL. April 2014. Abstract P1243. Sofosbuvir and Ribavirin in HCV Genotype 4 Egyptian Ancestry Trial: Study Features.

march
Download Presentation

Sofosbuvir + Ribavirin i n HCV GT 4 Egyptian Ancestry Trial

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Phase 2 Treatment Naïve and Treatment Experienced Sofosbuvir + Ribavirin in HCV GT 4Egyptian Ancestry Trial Ruane P, et al. 49th EASL. April 2014. Abstract P1243.

  2. Sofosbuvir and Ribavirin in HCV Genotype 4Egyptian Ancestry Trial: Study Features Source: Ruane P, et al. 49th EASL. April 2014: Abstract P1243.

  3. Sofosbuvir and Ribavirin in HCV Genotype 4Egyptian Ancestry Trial: Baseline Characteristics Source: Ruane P, et al. 49th EASL. April 2014: Abstract P1243.

  4. Sofosbuvir and Ribavirin in HCV Genotype 4Egyptian Ancestry Trial: Design Week 0 12 24 36 GT 4 Naïveor Experienced Sofosbuvir +RBV(n = 32) SVR12 Sofosbuvir + RBV(n = 28) SVR12 Drug DosingSofosbuvir: 400 mg once dailyWeight-Based Ribavirin (in 2 divided doses): 1000 mg/day if < 75 kg or 1200 mg/day if ≥ 75 kg Source: Ruane P, et al. 49th EASL. April 2014: Abstract P1243.

  5. Sofosbuvir and Ribavirin in HCV Genotype 4Egyptian Ancestry Trial: Results SVR 12 by Regimen Duration and Treatment Experience 11/14 14/14 10/17 13/15 Treatment Naive Treatment Experienced Source: RuaneP, et al. 49th EASL. April 2014: Abstract P1243.

  6. This slide deck is from the University of Washington’s Hepatitis C Online and Hepatitis Web Study projects. Hepatitis C Onlinewww.hepatitisc.uw.edu Hepatitis Web Studyhttp://depts.washington.edu/hepstudy/ Funded by a grant from the Centers for Disease Control and Prevention.

More Related